| 000 | 01811 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516213032.0 | ||
| 264 | 0 | _c20150302 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1651-1980 | ||
| 024 | 7 |
_a10.3109/00365548.2014.912348 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCampos, Paola A | |
| 245 | 0 | 0 |
_aA sustained endemic outbreak of vancomycin-resistant Enterococcus faecium: A 30-month surveillance study. _h[electronic resource] |
| 260 |
_bScandinavian journal of infectious diseases _cAug 2014 |
||
| 300 |
_a547-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAminoglycosides _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 |
_aCarbon-Oxygen Ligases _xgenetics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 | _aEndemic Diseases |
| 650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
| 650 | 0 | 4 | _aEpidemiological Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycopeptides _xtherapeutic use |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTertiary Care Centers |
| 650 | 0 | 4 |
_aVancomycin-Resistant Enterococci _xisolation & purification |
| 650 | 0 | 4 |
_aVirulence Factors _xgenetics |
| 700 | 1 | _aBatistão, Deivid W F | |
| 700 | 1 | _aGontijo-Filho, Paulo P | |
| 700 | 1 | _aRibas, Rosineide M | |
| 773 | 0 |
_tScandinavian journal of infectious diseases _gvol. 46 _gno. 8 _gp. 547-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/00365548.2014.912348 _zAvailable from publisher's website |
| 999 |
_c23829839 _d23829839 |
||